123: Lenacapavir for HIV Prevention
From Febrile by Sara Dong
July 7, 2025 · 35 min · Season 5 · Episode 123
About this episode
Drs. Anshel Kenkare and Mike Reid discuss lenacapavir, a newly FDA-approved drug for HIV prevention.
Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA. Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com Febrile is produced with support from the Infectious Diseases Society of America (IDSA)
People in this episode
Host: Sara Dong
Guests: Anshel Kenkare, Mike Reid
Topics covered
- HIV prevention
- lenacapavir
- FDA approval
- infectious diseases
- medical science
Keywords
- lenacapavir
- HIV
- prevention
- FDA
- infectious diseases
- medical research
Mentioned in this episode
Organizations: FDA
More episodes of Febrile
- 133: Pump and Circumstance: An update on VAD/MCS infections · May 11, 2026 · 24 min
- 132: Not Your Average Brodie · March 30, 2026 · 14 min
- 131: Do the H.U.S.T.L.E. · March 16, 2026 · 39 min
- 130: Trolls of Transplant with NephMadness 2026! · March 2, 2026 · 53 min
- 129: Cruzi'n USA · February 16, 2026 · 51 min
- 128: StAR: Complexities in CIED Infection · February 2, 2026 · 51 min
Explore listener stats, chart rankings, contacts and more on the Febrile podcast page.